People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

112.70CHF
29 Aug 2014
Price Change (% chg)

CHF1.50 (+1.35%)
Prev Close
CHF111.20
Open
CHF111.90
Day's High
CHF113.70
Day's Low
CHF111.30
Volume
331,125
Avg. Vol
588,816
52-wk High
CHF115.50
52-wk Low
CHF60.50

Search Stocks

Garnier, Jean-Pierre 

Brief Biography

Dr. Jean-Pierre Garnier, Ph.D., has been Chairman of the Board of Directors at Actelion Ltd since September 27, 2011. He joined the Company's Board of Directors on May 5, 2011. He is Member of the Compensation Committee, as well as of the Nominating and Governance Committee at the Company. He holds a Doctorate in Philosophy in Pharmacology and a Master of Science degree in Pharmaceutical Science from Louis Pasteur University, Strasbourg, France, as well as a Master of Business Administration degree from Stanford University, California, the United States. During his professional career Dr. Garnier has occupied various management positions at Schering-Plough. Within SmithKline Beecham, he was President of the pharmaceutical business in North America from 1990, elected to the Board of Directors in 1992, Chairman of Pharmaceuticals from 1994, Chief Operating Officer from 1995 and Chief Executive Officer (CEO) from April 2000. He was later First Chief Executive Officer of GlaxoSmithKline between 2001 and2008. Furthermore, he served as CEO of Pierre Fabre Labs in the years 2008 to2010. Apart from his duties to the Company, he is Chairman of the Board of Directors at NormOxys, Inc. and Member of the Board of Directors of United Technologies Corporation and Renault S.A. and of CerenisTherapeutics Inc. He is also Managing partner of Advent International Corporation. He holds Officier de Legion d’Honneur and Knight Commander of the British Empire.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
320,099 -- -- 320,099

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks